Date:
Thursday, February 1, 2007.
7:00 PM.

Location: Fairchild Auditorium, Stanford University Medical Center

<p>The main feature of hypertrophic </p> <p>Cardiomyopathy is an excessive </p> <p>thickening of the heart muscle </p> <p>(hypertrophy literally means to </p> <p>thicken). Heart muscle may thicken </p> <p>in normal individuals as a result of </p> <p>high blood pressure or prolonged </p> <p>athletic training. In hypertrophic </p> <p>cardiomyopathy, however, the </p> <p>muscle thickening occurs without </p> <p>an obvious cause and is often an </p> <p>inherited condition. The incidence of </p> <p>hypertrophic cardiomyopathy in the </p> <p>general population is 1 in every 500 </p> <p>people. HCM is the leading cause of </p> <p>sudden cardiac death in the young. </p> <p>This talk will focus on the nature </p> <p>of the disorder and the emerging </p> <p>research and array of treatments </p> <p>Stanford doctors use to treat it. </p> <p>Speaker: Euan Ashley, MRCP, </p> <p>DPhil, Assistant Professor, </p> <p>Cardiovascular Medicine, Stanford </p> <p>University Medical Center </p>